The largest database of trusted experimental protocols

Cd127 apc

Manufactured by BD
Sourced in Canada, France, Germany

CD127-APC is a fluorescently-labeled antibody that specifically binds to the CD127 antigen, also known as the Interleukin-7 receptor alpha chain (IL-7Rα). CD127 is expressed on the surface of various immune cells, including T cells, B cells, and NK cells. The APC (Allophycocyanin) fluorescent dye is conjugated to the antibody, allowing for flow cytometric detection and analysis of CD127-expressing cells.

Automatically generated - may contain errors

5 protocols using cd127 apc

1

Tumor-Infiltrating Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
M-chlorin e6 PDT was performed as described above. Mice were euthanized by cervical dislocation on day 2 after LED irradiation. The tumors were removed and treated with 10% collagenase (Wako), shredded using a gentleMACS™ Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany), and passed through a 70-μm filter. Next, 1.0 × 106 cells were mixed with 1 μL of Fc-block/100 μL of stain buffer (BD Biosciences, San Jose, CA) and left on ice for 10 min. Subsequently, 1 μL of fluorescent antibody (CD11b-APC [BD Biosciences], CD206-BV421 [Biolegend, San Diego, CA], CD80-PE [BD Biosciences], CD86-PE-Cy7 [BD Biosciences], CD45-PE-Vio®770 [Miltenyi Biotec], CD3-FITC [Miltenyi Biotec], CD8a-APC-H7 [BD PharMingen, San Diego, CA], CD127-APC [BD PharMingen], CD25-PE [BD Biosciences], or CD4-BV421 [Biolegend]) diluted with 100 μL of stain buffer was added and left on ice for 30 min. The cells were then washed with 500 μL of phosphate-buffered saline (PBS) and suspended in 500 μL of stain buffer. Next, 5 μL of 7-AAD (BD Biosciences) was added to prepare a sampling solution, which was analyzed on a BD FACSVerse™ (BD Biosciences).
+ Open protocol
+ Expand
2

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
A panel of monoclonal antibodies was developed to enable phenotypic characterization of B and T lymphocyte subpopulations: CD3-FITC, CD4-APC, CD25-BV421, FoxP3-PE, CD19-PeCy7, CD9-BB700 (BD Bioscience, France), CD24-BV510, and CD38-APC-Cy7 (Sony Biotechnology, UK); hematopoietic stem and progenitor cells: CD34-BV421 (Biolegend, France), cKit-APC-H7, CD135-PE, lineage-FITC, Sca-1-BV510, CD16/32-PerCPCy5.5, CD127-APC (BD Bioscience), and TLR-4-PeCy7 (Biolegend); and dendritic cells: CD11c-PeCy7 (eBioscience, France), CMH-II-FITC, Siglec-H-BV510, CD11b-APC-H7, and CD103-PerCP5. For intracellular staining, cells were fixed and permeabilized using a Cytofix/Cytoperm kit (BD Biosciences). For in vitro human B cell differentiation experiments, cells were stained with Fixable Viability Dye eFluor 450 to identify dead cells, followed by staining with CD25-BV605 (Biolegend), CD19-BUV395, CD9-FITC, CD27-BUV737, CD38-BV711 and intracellular IL-10-PE (BD Bioscience). Cells were analyzed on a Canto II flow cytometer (BD Biosciences). Data were acquired using Diva 8.0 software and analyzed with FlowJo X (TreeStar, Williamson Way, Ashland, USA). Fluorescence minus one staining controls were used for all panels, and dead cells were removed using viability staining.
+ Open protocol
+ Expand
3

Immunophenotyping of T-cell Subsets in HIV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte surface phenotypes were evaluated by flow cytometry on fresh peripheral blood of HIV-infected women alone, using fluorochrome-labeled antibodies: L/D-BV510 (Miltenyi Biotech, Germany); CD4-APC-H7, CD8-PE-Cy7, CD38-PE, CD45R0-PerCPCy5.5, CD45RA-PerCPCy5.5, CD127-APC, CD31-FITC, CCR7-APC, CD103-PE, CD95-FITC, CD69-FITC, PD1-PE (BD Biosciences, Palo Alto, CA).
T-cell subsets were defined as: naive CCR7+ CD45RA+, central memory CCR7+CD45RA, effector memory CCR7 CD45RA, and terminally differentiated CCR7 CD45RA+ subsets. Besides, we measured: activation (CD45R0/CD38/CD69), apoptosis (CD95), exhaustion (PD-1), IL7R (CD127), and Recent Thymic Emigrants (CD31 or CD103) on both CD4 and CD8 T-cell subsets.
Briefly, 1 × 106 peripheral blood mononuclear Cells were stained with the appropriate antibodies for 20 minutes at 4°C in the dark, washed and then acquired using FACSVerse cytometer (BD Biosciences, Palo Alto, CA).
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse anti‐human monoclonal antibodies against CD4‐PerCP, CD25‐FITC, CD127‐APC, CTLA‐4‐PE, CD11c‐PerCP Cy5.5, CD123‐APC 750, Lin‐APC, HLA‐DR‐FITC, and HLA‐DQ‐PE and mouse IgG1‐PE were purchased from BD Pharmingen and BECKMAN COULTER Inc. Red blood cell lysis buffer was purchased from BD Biosciences. The flow cytometer models were FACS‐Calibur (BD Biosciences) and CytoFLEX (BECKMAN COULTER). Analysis software FlowJo 7.6.1 (TreeStar) and CytExpert (BECKMAN COULTER) were used.
+ Open protocol
+ Expand
5

Evaluation of Spike Protein-Specific Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens from untreated and immunized mice were passed through a 40-mm cell strainer to obtain a single-cell suspension. Spleen cells were cultured with spike protein (S: 1µg/ml), or medium only. After 72 h of incubation, IFN-γ and IL-17A concentrations were quantified in supernatants by ELISA.
For FACS analysis, spleen cells that were not re-stimulated with Spike protein were incubated with CD16/CD32 FcgRIII (1:100) to block IgG Fc receptors. Cells were treated with LIVE/DEAD Violet (Invitrogen), followed by surface staining with fluorochrome-conjugated anti-mouse Abs for various markers: CD3-Pe-Cy7 (BD), CD8-PE (BD), CD4-FITC (BD), CD44-PE (BD), CXCR5-PerCP-Cy5.5 (BD), CD127-APC (BD). Flow cytometry analysis was performed on an BD FACSAria Fusion. The results were analyzed using FlowJo software (TreeStar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!